Key result
Dual-chamber ICDs were associated with a nonsignificant trend toward higher mortality and heart failure rates compared to single-chamber ICDs.
Why the study?
Does dual-chamber ICD compared to single-chamber ICD improve mortality or heart failure outcomes in patients with prior myocardial infarction and ejection fraction ≤0.30?
Observational (n=717)
Yes
Does dual-chamber ICD compared to single-chamber ICD improve mortality or heart failure outcomes in patients with prior myocardial infarction and ejection fraction ≤0.30?
In patients with prior MI and severe LV dysfunction receiving an ICD, the use of dual-chamber versus single-chamber devices did not significantly impact mortality or heart failure hospitalization rates.
Answers are grounded in this paper and cite their sources.
No outcome benefit with dual-chamber ICDs post-MI; leaves open optimal device selection pending randomized trials.
OBJECTIVES: We sought to evaluate the influence of single- versus dual-chamber implantable cardioverter defibrillators (ICDs) on the occurrence of heart failure and mortality as well as appropriate and inappropriate ICD therapy in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). BACKGROUND: In MADIT-II, ICD therapy in patients with a prior myocardial infarction and ejection fraction < or =0.30 was associated with a 31% reduction in risk of mortality when compared to conventionally treated patients. An unexpected finding was an increased occurrence of hospitalization for heart failure in the ICD group. METHODS: Data from 717 patients randomized to ICD therapy with single- or dual-chamber pacing devices in MADIT-II were retrospectively analyzed. Endpoints selected for analysis included death from any cause, new or worsening heart failure requiring hospitalization, death or heart failure, appropriate therapy for ventricular tachycardia (VT) or ventricular fibrillation (VF), and inappropriate ICD therapy for atrial fibrillation or supraventricular tachycardia. RESULTS: A total of 404 single-chamber ICDs (S-ICDs) and 313 dual-chamber ICDs (D-ICDs) were implanted. Patients receiving D-ICDs were at a higher risk at baseline than those receiving S-ICDs, with older age, higher NYHA class, more frequent prior CABG, wider QRS complex, more LBBB, higher BUN level, a history of more atrial arrhythmias requiring treatment, and a longer time interval from their index myocardial infarction to enrollment. While there was a trend toward an increase in adverse outcomes in the D-ICD group, no statistically significant differences in heart failure or mortality were observed between S-ICD versus D-ICD groups. CONCLUSIONS: Patients with D-ICDs had a nonsignificant trend toward higher mortality and heart failure rates than patients with S-ICDs.
No takes yet. Share an insight, caveat, or question.
Berenbom et al. (2005) conducted an observational in Prior myocardial infarction and ejection fraction ≤0.30 (n=717). Dual-chamber implantable cardioverter defibrillators vs. Single-chamber implantable cardioverter defibrillators was evaluated on Death from any cause, new or worsening heart failure requiring hospitalization, death or heart failure, appropriate therapy for VT/VF, and inappropriate ICD therapy. Dual-chamber ICDs were associated with a nonsignificant trend toward higher mortality and heart failure rates compared to single-chamber ICDs.
Synapse has enriched 10 related papers. Consider them for comparative context: